Locametz 25 micrograms kit for radiopharmaceutical preparation, -, Pluvicto 1 000 MBq/mL solution for injection/infusion
CAAA617A12101
Phase 1 small_molecule active
Quick answer
Locametz 25 micrograms kit for radiopharmaceutical preparation, -, Pluvicto 1 000 MBq/mL solution for injection/infusion for Metastatic Castration-Resistant Prostate Cancer is a Phase 1 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Metastatic Castration-Resistant Prostate Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active